Takeda Pharmaceutical TAK
NYSE TAK
$18.23 -0.11 (-0.63%)
At close: Aug 20, 2026 · 12:29 PM UTC

Takeda Pharmaceutical (TAK) Net Income towards Common Stockholders Growth (1y) (2018 - 2026)

Takeda Pharmaceutical (TAK) Net Income towards Common Stockholders Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Haleon 44.07 Bn 43.11 Bn - -
2 Teva Pharmaceutical Industries 43.27 Bn 39.61 Bn 2.15 Bn -304.98%
3 Zoetis 31.81 Bn 30.14 Bn 1.05 Bn -5.04%
4 Takeda Pharmaceutical 28.72 Bn 22.92 Bn 5.10 Bn -17.29%
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 7.59%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -2,482.61%
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn 34.33%
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 390.91%
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn -99.40%

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.29%
Mar 31, 2026 -2.72%
Dec 31, 2025 -252.74%
Sep 30, 2025 3.63%
Jun 30, 2025 40.33%
Mar 31, 2025 26.73%
Dec 31, 2024 -422.64%
Sep 30, 2024 -28.51%
Jun 30, 2024 -6.20%
Mar 31, 2024 -19.07%
Dec 31, 2023 -75.05%
Sep 30, 2023 342.84%
Jun 30, 2023 -19.67%
Mar 31, 2023 912.20%
Dec 31, 2022 65.92%
Sep 30, 2022 7.07%
Jun 30, 2022 -35.44%
Mar 31, 2022 -105.25%
Dec 31, 2021 -42.50%
Sep 30, 2021 998.23%